DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Mammen MP, Armas D, Hughes FH. , et al.
A First-in-human phase 1 study to assess safety, tolerability and pharmacokinetics of a novel antifungal drug VL-2397 in healthy adults.
Antimicrob Agents Chemother 2019; (e-pub ahead of print)
DOI: 10.1128/AAC.00969-19.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.